Allergan plc (AGN)

NYSE - NYSE Real Time Price. Currency in USD
251.57-1.64 (-0.65%)
As of 12:43 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close253.21
Bid250.78 x 100
Ask250.85 x 300
Day's Range250.55 - 254.90
52wk Range195.50 - 322.68
1y Target EstN/A
Market Cap99.61B
P/E Ratio (ttm)23.95
Avg Vol (3m)3,093,714
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Why no other drug maker was able to close the Medivation deal
    Editor's Pick
    Nicole Sinclair2 days ago

    Why no other drug maker was able to close the Medivation deal

    On Monday, Medivation (MDVN), which owns Xtandi, confirmed it was being acquired by Pfizer (PFE) for $14 billion. This comes just months after Sanofi (SNY) approached Medivation in a hostile deal, going public with its offer and beginning a process to replace the company’s board. Sanofi lost out on its bid to Pfizer, which was willing to pay up and fold Medivation into its oncology franchise.

  • Investopedia44 minutes ago

    Top 5 Shareholders of Allergan (AGN)

    Discover the top institutional and direct Allergan shareholders. Learn about their shareholdings and associations with the company.

  • TheStreet.com2 hours ago

    David Einhorn Cashed Out of These 9 Stocks

    The going has been a bit tough for David Einhorn lately, and he has been doing some selling in turn.